CTAGE5 Antibodies

Santa Cruz Biotechnology delivers a wide array of CTAGE5 monoclonal antibodies for investigating CTAGE5 protein function and expression. CTAGE5 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CTAGE5, or Cancer/Testis Antigen 5, is primarily expressed in testicular germ cells and various cancer tissues. CTAGE5 expression patterns have been linked to tumor progression, making it a promising biomarker for certain malignancies. Research has shown that CTAGE5 plays significant roles in cellular processes related to cancer development. Understanding CTAGE5 function and regulation can provide valuable insights into cancer biology. Ongoing studies continue to reveal new aspects of CTAGE5's involvement in different cancer types. Current research focuses on exploring CTAGE5's potential as a therapeutic target. CTAGE5 monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance cancer research and develop new therapeutic strategies.